Aromatase inhibitors in breast cancer survivors Dec. 06, 2012 Overview Show transcript Overview Sandhya Pruthi, director of the Breast Diagnostic Clinic at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on managing aromatase inhibitors in breast cancer survivors. Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoUse of radiotherapies in breast cancerVideoSigns of high risk breast cancerVideoGrand Rounds: Less Invasive Axillary Surgery After Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071 VID-20439982 Medical Professionals Aromatase inhibitors in breast cancer survivors